Mr Mrs Miss Ms Dr Other

Ms
Roxna
Kapadia

Patent Director

London Office

Life sciences

Telephone. +44(0) 207 776 5100
Mobile. +44(0) 735 042 6573
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.
Vcard
Linkedin

Experience

Roxna is a UK and European qualified Patent Attorney with a technical background in microbiology and immunology. She has in-depth knowledge and experience with viral cancer therapeutics, antibodies, microbiome, stem cells, immunotherapy, genetics and food science. Roxna has in-house patent experience working at the small biotechnology company Oncolytics Biotech Inc. and at the multinational company General Electric Healthcare and Merck Sharp & Dohme.

Roxna has experience working before the EPO, UKIPO and WIPO, including drafting and filing applications, prosecution and EPO oppositions and appeals. Roxna also has extensive experience with IP due diligence, validity opinions and FTO analysis. Having worked both in house and in private practice, Roxna is well placed to provide business focused strategic intellectual property advice to her clients.

Roxna is a named inventor on a patent for a method of purifying viruses using gel permeation chromatography. Roxna developed and ran industry-focused intellectual property courses in London UK, in particular Roxna has taught freedom to operate courses for the Life Sciences and Pharmaceutical Industry.

Having grown up in Canada and worked in Switzerland, Roxna is fluent in English and French.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

BSC

Microbiology and Immunology

MSC

Immunology

MSC

Management of Intellectual Property

Publications

Bite-sized MBA Course

View publication online

Divergent Roles of Toll-like Receptor 2 in Response to Lipoteichoic acid and Staphylococcus aureus In Vivo.

View publication online

The Use of Immunohistochemistry to Determine Oncolytic Reovirus Distribution and Replication In-Human Tumors.

View publication online

Conferences: 2023

21st November 2023

LSPN Europe 2023

Attended

Event details

Related News

HGF Sets the Gold Standard – Recognised for 7th Year in a Row by Financial Times

We are extremely honoured to announce that HGF has once again been ranked ‘Gold’ across all six bands in the Financial Times Special Report – Europe’s Leading Patent Law Firms …

Read article

HGF receives exceptional results in IAM Patent 1000 rankings 2025

We are proud to announce that HGF has once again achieved outstanding recognition in the IAM Patent 1000 – The World’s Leading Patent Professionals 2025. With 29 of our attorneys …

Read article

Innovation in the Energy Industry - Do You Have Freedom to Operate?

The energy transition has brought unprecedented change to the energy sector. Whilst change can bring uncertainty and challenges, it also brings opportunities. Many companies have already seized on the opportunity …

Read article

The Strawberry Patent Battle: Seeds, Speculation, and Jurisdiction

  This case, relating to infringement of a US plant patent, deals with the evidentiary burden required to show infringement of a plant patent in the US, as well as …

Read article
Event - 3rd June 2025

Salzburg Seminar: Patents, trademarks, intellectual property rights – how startups can act strategically

Young companies make many important decisions during the start-up phase. One of the most important questions is: How do I deal strategically with innovations, ideas, and brand development? Those who …

Event details

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article

Protecting inventions in Europe and beyond

A patent is  a form of registered intellectual property right granted for new, inventive and industrially applicable inventions. Patents are monopoly rights that  allow their owners (or licensees) the right …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us